Amneal Pharmaceuticals, Inc. (AMRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.95B |
| Enterprise Value | 6.37B |
| P/E Ratio | 40.34 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 2.06 |
| Price/Book Ratio | 193.99 |
| Enterprise/Revenue | 2.91 |
| Enterprise/EBITDA | 13.91 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | -3.27 |
Income Statement
| Revenue | 3.02B |
| Revenue/Share | 9.77 |
| Gross Profit | 1.14B |
| EBITDA | 603.87M |
| Net Income | 72.06M |
| Diluted EPS | 0.22 |
Balance Sheet
| Total Cash | 127.64M |
| Total Cash/Share | 0.4 |
| Total Debt | 2.79B |
| Total Debt/Equity | 84.54 |
| Current Ratio | 2.2 |
| Book Value Per Share | 0.37 |
Price History
| 52-Week Change | 93.35 |
| 52-Week High | 21.18 |
| 52-Week Low | 9.56 |
| Moving Average 50 Days | 18.23 |
| Moving Average 200 Days | 14.93 |
Statistics
| Average Volume | 2.11M |
| Shares Outstanding | 319.33M |
| % Held by Institutions | 50.31 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
